Co-inheritance of Specific Genotypes of HSPG and ApoE Gene Increases Risk of Type 2 Diabetic Nephropathy
Overview
Affiliations
The objective of this paper is to investigate co-inheritance of specific HSPG and ApoE genotypes in the development of Chinese type 2 diabetic nephropathy. PCR-RFLP was used to detect HSPG and ApoE genotypes in 385 Chinese subjects including 298 patients with type 2 diabetes mellitus (T2DM) and 87 non-diabetic controls (Non-DM). The T2DM group was subdivided into patients with (TDN; n = 218) and without diabetic nephropathy (Non-DN; n = 80). The latter group was further subdivided into groups of patients with microalbuminuria nephropathy (DN-1; n = 129) and severe diabetic nephropathy (DN-2; n = 89). We then compared the relative frequencies of various HSPG and ApoE genotypes and alleles among the groups, searching for predictive trends. The T allele of the HSPG gene occurred more frequently in the DN-2 group than in the Non-DN or DN-1 groups, their Fisher's exact p was 1.05 x 10(-3) and 6.58 x 10(-6); odds ratios were 2.09 (95% CI 1.32-3.30) and 2.48 (95% CI 1.64-3.74), respectively. The E2 allele of the ApoE gene occurred more frequently in the T2DM than in the Non-DM group, the Fisher's exact p was 0.0087; odds ratio was 3.45 (95% CI 1.30-9.81). Genotype analysis showed that the TT or TG of HSPG gene were paired with the E2/2 or E2/3 of ApoE gene significantly more frequently in the TDN group than in the Non-DN group, with an odds ratio of 3.03 (95% CI 1.03-8.90). There was no significant differences in other combinations of genotypes in HSPG and ApoE genes between TDN and Non-DN group. These results suggest that the HSPG T allele is a risk factor for the development of severe diabetic nephropathy in type 2 diabetic patients, and that the ApoE E2 allele is a risk factor for the occurrence of type 2 diabetes mellitus in Chinese general population. In addition, we find that co-inheritance of T/E2 confers a higher risk of type 2 diabetes mellitus progression to diabetic nephropathy in Chinese.
Taurbekova B, Mukhtarova K, Salpynov Z, Atageldiyeva K, Sarria-Santamera A BMC Nephrol. 2024; 25(1):436.
PMID: 39614174 PMC: 11607899. DOI: 10.1186/s12882-024-03859-6.
Shi J, Cheng Z, Qiu S, Cui H, Gu Y, Zhao Q Lipids Health Dis. 2020; 19(1):136.
PMID: 32534589 PMC: 7293775. DOI: 10.1186/s12944-020-01307-6.
Li T, Shi Y, Yin J, Qin Q, Wei S, Nie S Int Urol Nephrol. 2014; 47(1):117-30.
PMID: 25262148 DOI: 10.1007/s11255-014-0843-6.
Lin Y, Pan J, Jiang M, Tan J, Zhong W, Gong T Med Sci Monit. 2014; 20:1596-603.
PMID: 25196797 PMC: 4166221. DOI: 10.12659/MSM.892111.
APOE polymorphism and diabetic nephropathy.
Araki S Clin Exp Nephrol. 2013; 18(2):230-3.
PMID: 24026386 DOI: 10.1007/s10157-013-0862-0.